You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent Non-Muscle Invasive Bladder Cancer (NMIBC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

Not yet recruiting
  • Bladder Cancer
  • +5 more
  • Bacillus Calmette-Guerin: Strain Russian BCG-I
  • Bacillus Calmette-Guerin: Strain TICE
  • (no location specified)
Apr 7, 2022

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • HER2
    • (no location specified)
    Jul 16, 2023

    High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

    Not yet recruiting
    • High-risk Non-muscle Invasive Bladder Cancer
    • (no location specified)
    Oct 25, 2023

    Uromonitor asBiomarker for Optimization of NMIBC Management by

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      May 9, 2023

      Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

      Recruiting
      • Non Muscle Invasive Bladder Cancer
      • N803 plus Bacillus Calmette-Guerin (BCG)
      • Honolulu, Hawaii
        Island Urology
      Aug 7, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
        • Little Rock, Arkansas
        • +2 more
        Aug 6, 2023

        Urine-based Molecular Testing vs Cystoscopy for Surveillance of

        Not yet recruiting
        • Non-muscle Invasive Bladder Cancer
        • +2 more
        • CxBladder Monitor
        • Cystoscopy
        • Scottsdale, Arizona
        • +2 more
        Nov 14, 2023

        Non-muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Nashville (ABI-009, Gemcitabine)

        Completed
        Has Results
        • Non-muscle Invasive Bladder Cancer (NMIBC)
        • New York, New York
        • +1 more
        May 12, 2021

        Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

        Recruiting
        • Urothelial Carcinoma
        • Non-Invasive Bladder Urothelial Carcinoma
        • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
        • Tampa, Florida
          Moffitt Cancer Center
        Mar 2, 2023

        Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

        Active, not recruiting
        • Non-muscle-invasive Bladder Cancer
        • Gemcitabine 1000 mg, Docetaxel 37.5g
        • Zagreb, Croatia
          University Hospital Centre Zagreb
        Jan 20, 2023

        Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

        Not yet recruiting
        • Non Muscle Invasive Bladder Cancer
        • +3 more
        • Cretostimogene Grenadenorepvec
        • n-dodecyl-B-D-maltoside
        • (no location specified)
        Oct 30, 2023

        Non-muscle Invasive Bladder Cancer Trial (TARA-002)

        Not yet recruiting
        • Non-muscle Invasive Bladder Cancer
        • TARA-002
        • (no location specified)
        Jul 14, 2023

        Bladder Cancer Trial in Nara, Okayama (FE 999326)

        Recruiting
        • Bladder Cancer
        • FE 999326
        • Nara, Japan
        • +1 more
        Jan 19, 2023

        Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

        Terminated
        • Non-muscle Invasive Bladder Cancer (NMIBC)
        • Hyaluronic Acid (HA) sodium salt and Hydeal-D
        • Rozzano, Mi, Italy
          Humanitas Research Hospital
        Sep 29, 2023

        Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • (no location specified)
        Sep 9, 2022

        Bladder Cancer Trial in Roskilde (Urine test)

        Recruiting
        • Bladder Cancer
          • Roskilde, Denmark
            Zealand University Hospital
          Oct 5, 2022

          Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202 in combination with Epirubicin, Placebo in combination with

          Active, not recruiting
          • Non-muscle Invasive Bladder Cancer
          • APL-1202 in combination with Epirubicin
          • Placebo in combination with Epirubicin
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cancer Center
          Feb 21, 2022

          Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

          Recruiting
          • Bladder Cancer
          • +2 more
          • Basking Ridge, New Jersey
          • +6 more
          Aug 22, 2022

          Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • Standard infusion chemotherapy
          • BL - 5 ala PDT
          • Xi'an, Shaanxi, China
            Dalin He
          Sep 19, 2022

          Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

          Active, not recruiting
          • Bladder Cancer
          • +2 more
          • Homewood, Alabama
          • +4 more
          Dec 15, 2022

          Non-Muscle Invasive Bladder Cancer Trial in Aarhus (Laser ablation)

          Recruiting
          • Non-Muscle Invasive Bladder Cancer
          • Laser ablation
          • Aarhus, Denmark
            Aarhus University Hospital
          Aug 5, 2022